Treatment of adult patients with immune thrombocytopenia after failure of first-line therapies


( Last Updated : September 27, 2021)
Project Status:
In Progress
In Progress
Project Line:
Health Technology Review
Project Sub Line:
Health Technology Assessment
Project Number:
HT0035-000
Effective finish date:

Details


Immune thrombocytopenia (ITP) is a disorder characterized by low platelets and an increase in bleeding risk due to increased platelet destruction and impaired platelet production.

This project will review the place in therapy of available treatments for adults with ITP who have already received first-line therapies.


Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.

The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.